CAREDX, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M | $192.2M | $127.1M |
| Cost of Revenue | — | — | — | — | — | — | — | $45.5M |
| Gross Profit | — | — | — | — | — | — | — | $81.6M |
| Gross Margin | — | — | — | — | — | — | — | 64.2% |
| Operating Expenses | ||||||||
| Research & Development | — | $71.4M | $72.5M | $82.4M | $90.4M | $76.5M | $48.9M | $30.7M |
| SG&A Expense | — | $107.6M | $125.1M | $118.8M | $100.4M | $75.0M | $48.8M | $36.5M |
| Operating Income | — | $-30.8M | $40.8M | $-203.4M | $-77.2M | $-29.7M | $-22.5M | $-24.5M |
| Operating Margin | — | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% | -19.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-21.1M | $52.9M | $-190.1M | $-76.2M | $-32.1M | $-19.8M | $-23.9M |
| Income Tax Expense | — | $271.0K | $310.0K | $141.0K | $379.0K | $-1.4M | $-1.0M | $-2.0M |
| Net Income | — | $-21.4M | $52.5M | $-190.3M | $-76.6M | $-30.7M | $-18.7M | $-22.0M |
| Net Margin | — | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% | -9.7% | -17.3% |
| EPS (Basic) | — | $-0.40 | $1.00 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 |
| EPS (Diluted) | — | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 |
| Shares Outstanding (Basic) | 51.2M | 53.3M | 52.8M | 53.8M | 53.3M | 52.2M | 46.5M | 42.2M |
| Shares Outstanding (Diluted) | 51.2M | 53.3M | 56.6M | 53.8M | 53.3M | 52.2M | 46.5M | 42.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |